L
8.25
-0.05 (-0.60%)
| Previous Close | 8.30 |
| Open | 8.34 |
| Volume | 96,833 |
| Avg. Volume (3M) | 167,967 |
| Market Cap | 309,097,408 |
| Price / Earnings (Forward) | 8.67 |
| Price / Sales | 2.21 |
| Price / Book | 197.99 |
| 52 Weeks Range | |
| Earnings Date | 2 Jan 2026 |
| Profit Margin | -34.27% |
| Operating Margin (TTM) | -6.52% |
| Diluted EPS (TTM) | -1.47 |
| Quarterly Revenue Growth (YOY) | -1.50% |
| Total Debt/Equity (MRQ) | 274.83% |
| Current Ratio (MRQ) | 2.71 |
| Operating Cash Flow (TTM) | 2.69 M |
| Levered Free Cash Flow (TTM) | -27.28 M |
| Return on Assets (TTM) | -3.11% |
| Return on Equity (TTM) | -83.58% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Bullish | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Bullish | Mixed | |
| Stock | Lifecore Biomedical, Inc. | Mixed | Bearish |
AIStockmoo Score
0.4
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | 0.38 |
|
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Core |
| % Held by Insiders | 2.06% |
| % Held by Institutions | 72.40% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Greenhaven Road Investment Management, L.P. | 30 Sep 2025 | 3,694,832 |
| Dcf Advisers, Llc | 30 Sep 2025 | 452,000 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |